The COVID-19 pandemic has magnified systemic failures across health care locally and globally—from depleted public health infrastructures, fragmented delivery systems, and unacceptable outcome disparities. Ariadne Labs has been focused on developing evidence-based solutions to support clinicians, patients, the general public, and public health decision-makers. Our COVID-19 response builds on our core strengths—the ability to quickly convene, converge, and gather best ideas and practices; design and test guidelines and tools; and then strategically disseminate them as widely as possible through the many channels available to us.
Focus Areas
Supporting systems to deliver vaccines with speed, scale, and equity as supply and demand shift over time.
LEARN MORE
Focusing on communicating simple, easy to use information for the general public to mitigate the exposure and spread of COVID-19.
LEARN MORE
A global response can aid in ensuring equitable, efficient COVID-19 responses.
LEARN MORE
Innovating around the impacts of COVID-19 on obstetric services from prenatal, labor and delivery, and postnatal care.
LEARN MORE
Resources for patients and providers to offer guidance and best practices to ensure safe, effective outpatient care.
LEARN MORE
Resources to help health systems and providers navigate the impact of COVID-19 to ensure the safety of patients and the health care workforce.
LEARN MORE
Tools and resources for adults over the age of 65 and those with pre-existing health risks who at higher risk of severe illness from COVID-19.
LEARN MOREHighlights
Ariadne Labs’ Home Hospital team was on the ground in North Carolina this month as Atrium Health showcased a prototype of a new mobile hospital hub designed to bring hospital-level care directly to rural communities. The milestone was featured by WSOC-TV, which highlighted the urgent need for faster, closer access to care in underserved areas.… Continue reading Ariadne Labs and Atrium Health Showcase Mobile Hospital Hub Prototype in North Carolina
Dr. Namita Seth Mohta highlights our Aging and Illness work in this The New York Times article about the importance of communication and planning with aging parents.
Six states and one U.S. territory selected to assess feasibility of integrating whole genome sequencing into public health newborn screening Boston, MA Investigators leading BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening) today announced two major milestones in an NIH-funded research effort to evaluate genomic newborn screening: the selection of participating state… Continue reading BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study